ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
Aloysius
|
574 |
197K |
4 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
574
|
197K
|
4
|
|
ASX - By Stock
|
BOT |
NDA and PDUFA
|
|
Aloysius
|
2 |
925 |
0 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
2
|
925
|
0
|
|
ASX - By Stock
|
NEU |
Re:
FDA Approved
|
|
Aloysius
|
25 |
9.6K |
3 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
25
|
9.6K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
FDA Approved
|
|
Aloysius
|
25 |
9.6K |
0 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
25
|
9.6K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
FDA Approved
|
|
Aloysius
|
25 |
9.6K |
8 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
25
|
9.6K
|
8
|
|
ASX - By Stock
|
NEU |
FDA Approved
|
|
Aloysius
|
25 |
9.6K |
10 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
25
|
9.6K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Aloysius
|
17K |
6.7M |
12 |
21/10/21 |
21/10/21 |
ASX - By Stock
|
17K
|
6.7M
|
12
|
|